Researchers randomly assigned more than 400 individuals with rheumatoid arthritis to placebo or a new selective janus kinase 1 inhibitor to determine efficacy in improving symptoms of rheumatoid arthritis.
...
The authors of a new study assessed the relationship between atherosclerosis risk and rheumatoid arthritis remission among more than 700 individuals. The findings were presented at EULAR 2019.
The Danish Rheumatism Association surveyed more than 1000 individuals with a rheumatic or musculoskeletal disease to determine the influence of chronic pain on sleep, mental health, and the use of strong...
The authors of a new study compared the prevalence of various comorbidities among more than 800 individuals with RA with control cases, as well as investigated the time of comorbidity development relative...
The authors of a new study presented at the Annual European Congress of Rheumatology compared the risk of cancer among individuals with PsA who received treatment with TNF inhibitors with the risk of cancer...
In a new study, researchers compared the individual safety and efficacy of cyclosporine, mycophenolate mofetil, and azathioprine as long-term maintenance therapies among individuals with lupus nephritis. ...
In a first-in-human pilot study, researchers investigated the safety and efficacy of a novel miniaturized neurostimulator among individuals with active, refractory rheumatoid arthritis.
In a new study to be presented at the Annual European Congress of Rheumatology, researchers compared disease activity, quality of life, and work productivity of more than 2500 individuals with PsA, with and...
The authors of a new study presented at the Annual European Congress of Rheumatology evaluated more than 6000 cases of gout and matched control cases to determine if occupational exposure to inorganic dust...
Researchers from Brigham and Women’s Hospital evaluated whether the new zoster vaccine recombinant, adjuvanted, could induce flares among 300 individuals with rheumatoid arthritis or other systemic...
